AXIM BIOTECHNOLOGIES, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $91.53 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-23.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2021-08-23
- AXIM BIOTECHNOLOGIES, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2021-06-30 was $91.53K.
- AXIM BIOTECHNOLOGIES, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2021-03-31 was $99.74K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month |
|---|---|---|
| 2021-06-30 | $91.53K 10-Q · filed 2021-08-23 | $191.27K derived: sum of 2 quarters · filed 2021-08-23 |
| 2021-03-31 | $99.74K 10-Q · filed 2021-08-23 |